A Randomized, Double-Blind Comparison of Oral Aprepitant Alone Versus Oral Aprepitant and Transdermal Scopolamine for Preventing Postoperative Nausea and Vomiting - Contacts and Locations

A Randomized, Double-Blind Comparison of Oral Aprepitant Alone Versus Oral Aprepitant and Transdermal Scopolamine for Preventing Postoperative Nausea and Vomiting

This study is currently recruiting participants.

Study NCT00659737. Last updated on June 9, 2008. Information provided by Drexel University

Please refer to this study by its ClinicalTrials.gov identifier: NCT00659737

Contacts


Contact: Michael Green, DO	215-762-1524	Michael.Green@DrexelMed.edu

Locations


United States, Pennsylvania
	Hahnemann University Hospital	Recruiting
	Philadelphia, Pennsylvania, United States, 19102
	Contact: Michael Green, DO 215-762-1524 Michael.Green@DrexelMed.edu
	Principal Investigator: Michael Green, DO

Sponsors and Collaborators

Drexel University

Merck

Investigators


Study Director:	Jay Horrow, MD	Drexel University College of Medicine